chrisvoncsefalvay/vaers-outcomes huggingface dataset:
YOUTH HERE FOR TDAP IMMUNIZATION. TEMP 98.7 AT TIME OF VACCINATION. NO ALLERGIES, ILLNESS, OR PROBLEMS RECENT OR WITH PAST IMMUNIZATIONS. ADMINISTERED TDAP TO RIGHT DELTOID. WAS PREPARING FOR ADMINISTRATION OF MCV4 VACCINE WHEN YOUTH SAID SHE DIDNT FEEL WELL. SHE BECAME VERY PALE AND LEVEL OF CONSCIOUSNESS DELINED AND WOULD NOT RESPOND TO MY VERBAL. HER ARMS/TORSO BECAME VERY RIGID, SHE HAS SOME JERKING, AND HER EYES ROLLED BACK FAR. APPROXIMATELY LASTED 20 SECONDS. PLACED HER IN FRONT OF FAN, SUPPORTED HER FROM ANY INJURY. INSTRUCTED MOTHER TO CALL 9-1-1. STUDENTS LEVEL OF CONSCIOUSNESS IMPROVED AND BECAME RESPONSIVE.  SHE LEFT VIA EMS FOR FURTHER EVAL AND TREATMENT.
?COVID arm?  Swollen firm arm at sight of injection with itching, no rash
Mom had vax on a Monday afternoon and then had a stroke that night. I?m not sure of the exact dates.
Vasovagal Syncope, 10 minutes post vaccine, lasting a few hours. Dizziness, clammy skin, hot flashes, nausea. Metallic taste in mouth intermittent for about an hour following event. Starting 90 minutes post-vaccine, temporary facial tingling on lower left side of face. Subsided within one hour.
Had to go to bed pretty much all day; I was very sick; Headache; Nausea; . This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than a day after receiving Shingles vaccine, the patient experienced sickness, headache, nausea and activities of daily living impaired. On an unknown date, the outcome of the sickness, headache, nausea and activities of daily living impaired were recovered/resolved.   It was unknown if the reporter considered the sickness, headache, nausea and activities of daily living impaired to be related to Shingles vaccine.   Additional details was reported as follows: The age at vaccination was not reported. The age group was not reported but captured adult as per vaccine indication. The patient received Shingles vaccine and was sick within 4 hours of receiving it, had headache, nausea and had to go to bed pretty much all day but next day was good. The patient received 2nd dose but had no problems with it
Erythematous patch (7x7 cm) with pain and swelling. Painful in evening after vaccination, painful and red the next morning, progressively getting bigger.
Dizziness, headaches, diarreah, fever, ER on 02/08/2021 was given 2 bags of fluid. Ear began swelling, loss of apetite, neck and scalp itchy.
Receive vaccine 5/2/07 L deltoid. No initial reaction (no fever, pain, swelling at site). On 5/9/07 noticed painful swelling L deltoid with redness, increased to maximum size evening 5/9/07. Pt seen on 5/10/07 and had 2 1/2 cm subcutaneous erythematous area of induration - mobile, mildly tender on left deltoid (pt said smaller then previous night). On phone following 5/12/07 pt said swelling almost gone (only small bump - nontender).
Chills; she can't keep warm; nauseated; Cough; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6200), via an unspecified route of administration in right arm on 25Feb2021 10:00 (at the age of 83-years-old) as dose 2, single for COVID-19 immunization. Medical history included none. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN5318), via an unspecified route of administration in right arm on 28Jan2021 10:00 (at the age of 83-years-old) as dose 1, single for COVID-19 immunization. There were no concomitant medications. Prior to vaccination, the patient did not receive any vaccines within four weeks and no other vaccines administered on same date of BNT162B2. The patient experienced nauseated on 18Mar2021, cough on an unspecified date in Mar2021, chills and she can't keep warm on an unspecified date. Patient was asking if she has COVID or if she should get tested for COVID after receiving both COVID-19 Vaccines. She stated that she has been nauseated off and on, in the last week or so. She didn't have it right away, she just had it about for the last week. She stated that she also had chills and was wondering if she has COVID and should get tested because she has a dentist appointment tomorrow. Patient had nausea this morning, but she doesn't have it right now, it comes and goes. Patient had chills, she doesn't know if the shot did or something else, but she has been having those. Patient doesn't remember the day it started but she has had them every once and a while, and that she can't keep warm. She also stated that she has had a cough for seven days ago. Patient confirmed that she has not gone to the emergency room or doctor's office, she has just been eating soda crackers. No treatment was received for the events. Outcome of event nauseated, Chills and she can't keep warm was not resolved. Event Cough was resolving.  No follow-up attempts are possible. No further information is expected.
Symptoms started @ 10PM 10/17/08.  Pt c/o chills fever, achey muscles, lethargy.  Pain in back, decrease appetite- 1 wk duration.  Wife has same signs + symptoms but had no flu shot.
When patient presented for dose 2 she complained that after dose 1 she immediately had tingling in her arm.  Then had frozen shoulder symptoms for 1 week.  Seen by MD and symptoms resolved completely.
Menstrual cycle is 5 days late, periods are always normal and only thing different is the vaccine.
acute Bell's Palsy rt face 27 days p/vax; rx in urgent care w/pred & Famvir;8 days later 50-70% resolved;
Received TD 08/24/2005 approx. 12 noon. On 08/25/2005 7:30am awoke with confluent red rash flexor surface bilateral forearms, low abdomen and entire legs, thighs to ankles, with out itching, resolved with Benadryl x1 24 hrs. Later onset  bil wrist pain 24 hours after wrist pain, onset bil. knee pan and left shoulder pain. Describes as severe, worsened by moving and flexing affected joints, some improvement with use of Aleve arthritis.
chills presure in head and ears. Headaches, nausea, dizziness. It's been going on for4 months without any relief
patient who had pain for almost 2 weeks; This non-serious case was reported by a nurse via sales rep and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: patient who had pain for almost 2 weeks). The outcome of the pain was resolved (duration 2 weeks).   It was unknown if the reporter considered the pain to be related to Shingrix.     It was unknown if the company considered the pain to be related to Shingrix.   Additional Information: GSK Receipt Date: 20-JUN-2023. The reporter mentioned there was a patient who had pain for almost 2 weeks. The reporter did not consent to follow up.
administration of expired moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of expired moderna vaccine) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of expired moderna vaccine). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED (administration of expired moderna vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vaccines were stored in freezer and one to two vials were taken out and placed in fridge each day. No concomitant medications were reported. No treatment medications were reported.
Information has been received from a physician via a company representative concerning a 19 year old female patient who was vaccinated with 0.5 ml second dose of Gardasil. Subsequently the patient experienced urinary tract infection. Unspecified medical attention was sought. Additional information has been requested.
Mental fogginess, to the point a coworker had to drive him home. In the evening became achy all over severe arm pain at injection site, and temperature. Phoned PCP who told to go to the ER and he did not. went to PCP office 2/1/21.
Patient complained of tiredness the evening of the shot but couldn't sleep due to a feeling of anxiety and the feeling of bugs crawling under her skin. This anxiety and feeling of bugs continued Tuesday and Wednesday. Sent to other ER Wednesday afternoon when patient notified RN of a above reaction. Left arm achy. Not red or swollen. Had fever, low grade on Monday evening.
Shortness of breath within 30 minutes of receiving the vaccine; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 31Mar2021 at 13:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 31Mar2021 at 14:15, the patient experienced shortness of breath within 30 minutes of receiving the vaccine, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shortness of breath, headache and fatigue were resolved on an unknown date 2021.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a physician via a company representative, refers to a patient (Encounter key# 461882) of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 05-FEB-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB "10Pk 10mcg/1mL SD LL0k Cap AD", lot L001441 with expiration date 17-AUG-2017 (route of administration and anatomical location were not reported). There were no concomitant therapies and adverse effects reported. No product quality complain was involved. On an unspecified date, the RECOMBIVAX HB had six temperature excursion of 33 F (0.5 Celsius Degrees) for 168 hours, 29 F (-1.6 Celsius Degrees) for 256 hours, 30 F (-1.1 Celsius Degrees) for 264 hours, 32 F (0 Celsius Degrees) for 352 hours, 34 F (1.1 Celsius Degrees) for 88 hours and 31 F (0.5 Celsius Degrees) for 552 hours, respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and type of excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
Covid monitoring documentation. PT admitted 1/17/22 documented to have positive covid. PT received Pfizer 2/25/21 Lot EN6200 for dose 1. Dose 2 was Pfizer given on 3/18/21 Lot EN6204. PT received Pfizer Booster on 8/19/21 Lot FC3180.
pericardial tab; Phlebotomy remove iron from body; BNT162b2 and influenza vaccinated on the same day; BNT162b2 and influenza vaccinated on the same day; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old patient received bnt162b2 (BNT162B2), administered in arm right, administration date 29Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "kidney replacement" (unspecified if ongoing), notes: transplant years 5 ago; "Liver Biopsy" (unspecified if ongoing); "Eye glasses" (unspecified if ongoing); "immune compromised" (unspecified if ongoing). Concomitant medication(s) included: INFLUENZA, administration date 29Nov2021. Vaccination history included: Bnt162b2 (Dose 1), administration date: 07Oct2021, for COVID-19 immunization; Bnt162b2 (Dose 2), administration date: 28Oct2021, for COVID-19 immunization. The following information was reported: PERICARDIAL DISEASE (medically significant), outcome "unknown", described as "pericardial tab"; PHLEBOTOMY (medically significant), outcome "unknown", described as "Phlebotomy remove iron from body"; OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 29Nov2021, outcome "unknown" and all described as "BNT162b2 and influenza vaccinated on the same day". Specific relevant test for thromboembolic events with thrombocytopenia was none. Monitor testosterone level kidney. Med diet. 2 family members died of heart disease. Grand parent died of cancer.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101342098 same patient/product, different dose/event
Received flu vaccine 10/27/10. 10/28/10 complaints of upset stomach with funny taste in mouth. 10/29/10 feels better but funny taste still present on tongue.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.  It was reported that there have been no power outages that would have impacted the Moderna vaccine. However, reporter reiterated that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger that caller was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. Reporter said that they were filling out a temperature excursion assessment with the State at this time and she was calling in to report the same to Moderna. Reporter confirmed that patients have been administered doses while the temperature excursion assessment has been ongoing.  It was reported that no adverse reactions were reported by any patients.  No treatment information was provided.
Soreness in arm has not subsided in just under two weeks. Patient has tried OTC analgesics, ice, and was referred to a Physical Therapist.
Information was received from a registered nurse, referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not provided. On an unknown date, the patient was vaccinated with PROQUAD (lot # M044020 with expiration date 01-MAY-2018; concentration, dose, route and frequency were unknown) for prophylaxis, instead of M-M-R II. The nurse stated that the pharmacy had given them the wrong box of medication. No adverse effects were reported. No product quality complaint (PQC) was involved in this case.
It is stated that the pt is,"out of it, sleeping all the time and opens eyes and stares."
redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot; redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot; redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot; redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot; redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot), SWELLING (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot), INJECTION SITE MASS (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot), PRURITUS (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot) and INJECTION SITE WARMTH (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ERYTHEMA (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot), SWELLING (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot), INJECTION SITE MASS (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot), PRURITUS (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot) and INJECTION SITE WARMTH (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot), SWELLING (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot), INJECTION SITE MASS (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot), PRURITUS (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot) and INJECTION SITE WARMTH (redness and swelling where the needle went in, they had a hard bump, and it is itchy and hot) outcome was unknown.            No relevant concomitant medications reported.  Treatment information include Benadryl and ice pack.  Action taken with m-RNA-123 is not applicable.   Reporter did not allow further contact
Patient stated that she was having difficulty swallowing and talking. O2sat remained high at 100%. Rapid Response called with approximate 15 second response time from Code Team. 50mg Benadryl given IM via the right deltoid, shortly followed by epinephrine to right vastus lateralis. Patient O2sat remained above 90% at all times during reaction. Patient brought to ED via wheelchair with Code Team with intentions of an inpatient admission to follow.
Pain, numbness tingling in lower left arm; keeping arm bent as forearm and wrist hurt. Pt guarding arm distal to injection site. No site reaction.
I was vaccinated with the Fluzone on my left arm at around 3:40 PM. I felt a tingling penetration to the left side of my head. At about 5:00 PM, I had a headache on the left back side region. My headache feels like a theres lot of pressure. I would rate the headache on a scale from 1 to 10, 10 being the worst, I rate it an 8. The headache lasted all day, it is now 10:35 PM and has slightly subsided to a 6 out of 10.
Salivary glands swollen onboth sides having quite abit of pain, unable to chew-high temp; also has stomach pain;
Couldn't bear weight on leg for 12 hours, shooting pain.  2-3 weeks after vaccination.; Couldn't bear weight on leg for 12 hours, shooting pain.  2-3 weeks after vaccination; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for COVID-19 Immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for COVID-19 Immunization. The following information was reported: WEIGHT BEARING DIFFICULTY (non-serious), outcome "recovered", described as "Couldn't bear weight on leg for 12 hours, shooting pain. 2-3 weeks after vaccination."; PAIN (non-serious), outcome "recovered", described as "Couldn't bear weight on leg for 12 hours, shooting pain. 2-3 weeks after vaccination". Therapeutic measures were not taken as a result of weight bearing difficulty, pain.  Additional information: Facility type vaccine was reported as unknown. Patient did not receive any other vaccine in four weeks. Other medication in 2 weeks was reported as unknown. Patient did not have COVID prior vaccination. It was unknown if the patent tested positive post vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
no adverse event but discovered when billing a rejection by insurance. Checked impactsis and discovered patient had already received J and J vaccine on 6-8-21 and Moderna on 4-15-21 and 5-28-21 and then received a moderna series from us on 6-18 and today 7-16-21.
I live in the town where my Doctor is. I was shortly have pain right after I received the shot.  During the night I was in so much pain in my arm where the shot was given I could hardly sleep.  I called the doctors office the next day asking if they maybe got my shot mixed up with my daughter tentanus.   They replied no.  It has has been a month now.  I lost use of my left arm.  I symptons have not gone away. I have burning, weekness, and can not hold much in my left hand anymore.
Post vax, the pt broke out with chicken pox all over body, at least 50-100 marks.
Pt was presented to the physicians office with a mild case of chickenpox. Pt had approximately 28 pox on his right arm and left cheek, a normal temperature and no malaise.